Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Exane BNP Paribas Initiates Coverage On Lear with Underperform Rating

Exane BNP Paribas initiates coverage on Lear (NYSE:LEA) with a Underperform rating.

byBenzinga Newsdesk

April 11, 2022

1 minute read

Exane BNP Paribas initiates coverage on Lear (NYSE:LEA) with a Underperform rating.

Deutsche Bank Maintains Hold on RLJ Lodging, Lowers Price Target to $15

By Benzinga Newsdesk

October 25, 7:29 AM

Deutsche Bank analyst Chris Woronka maintains RLJ Lodging (NYSE:RLJ) with a Hold and lowers the price target from $17 to $15.

RLJ

BTRS Holdings Q4 EPS $(0.10) Misses $(0.08) Estimate, Sales $42.88M Beat $33.08M Estimate

By Benzinga Newsdesk

March 1, 5:40 PM

BTRS Holdings (NASDAQ:BTRS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 233.33 percent decrease over losses of $(0.03) per share from the

BTRS

Analyst Ratings

7 Analysts Have This to Say About Regeneron Pharmaceuticals

By Benzinga Insights

May 31, 2:24 PM

Over the past 3 months, 7 analysts have published their opinion on Regeneron Pharmaceuticals (NASDAQ:REGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

REGN